权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

CT-Based Diagnosis of Diffuse Coronary Artery Disease

基于 CT 的弥漫性冠状动脉疾病诊断

基本信息

批准号：
8274323
负责人：
GHASSAN S KASSAB
金额：
$ 40.91万
依托单位：
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
起止时间：
2009-08-01 至 2014-05-31
项目状态：
已结题

项目摘要

DESCRIPTION (provided by applicant): Atherosclerosis remains the major cause of morbidity and mortality in the U.S. Diffuse Coronary Artery Disease (DCAD), a common form of atherosclerosis, is especially difficult to diagnose because the lumen cross- sectional area (CSA) is diffusely smaller than the normal along multiple vessels. Typically, for patients with even mild segmental stenosis, lumen CSA is diffusely reduced by 30-50%. Whereas angiography has been the "gold standard" in the definition of focal stenosis of coronary artery, its viability to diagnose DCAD remains questionable. Hence, there is a significant clinical need for novel strategy to diagnose DCAD. The general objective of this proposal is to develop novel indices for diagnosis of DCAD using non-invasive imaging of the coronary arteries that are translatable to the patient. The matrices of diagnosis will be validated in studies of an atherosclerotic porcine model with DCAD. The central hypothesis is that the design of the human coronary arterial tree obeys a principle of minimum energy which results in a set of scaling laws; i.e., power-law relations between diameters, lengths, volumes and flows. An additional hypothesis is that the scaling laws can be used as sensitive measures of DCAD. The scaling laws provide the signature of "normal" vasculature and deviations from these laws can be used to quantify the extent of DCAD. Our unique atherogenic large animal model and computerized tomography (CT) images of normal and disease patients along with our quantitative approach uniquely position us to undertake the proposed research. To achieve this objective, we set the following four Specific Aims: 1) To develop a validated segmentation algorithm for extraction of morphometric data (diameters and lengths) from CT images; 2) To determine diagnostic indices of DCAD in an atherosclerotic DCAD porcine model using data obtained from CT images in Aim 1 based on morphometric scaling laws; 3) To validate the indices of DCAD predicted in Aim 2 using IVUS in vivo and histopathology in postmortem hearts; and 4) To use the validated indices of DCAD in a retrospective cohort of medically well-defined normal and DCAD patients. The contribution of this proposal will be to provide an integrated analysis of the epicardial coronary artery tree visible in routine imaging to allow diagnosis of DCAD. PUBLIC HEALTH RELEVANCE: Atherosclerosis remains the major cause of morbidity and mortality in the U.S. Diffuse Coronary Artery Disease (DCAD), a common form of atherosclerosis, is especially difficult to diagnose because the lumen cross-sectional area is diffusely smaller than the normal along multiple vessels. The contribution of this proposal is to provide an integrated analysis of the epicardial coronary artery tree visible in routine imaging to allow diagnosis of DCAD.

描述（由申请人提供）：动脉粥样硬化仍然是美国发病率和死亡率的主要原因。弥漫性冠状动脉疾病（DCAD）是动脉粥样硬化的一种常见形式，尤其难以诊断，因为管腔横截面积（CSA）沿多条血管弥漫性小于正常沿着血管。通常，即使是轻度节段性狭窄的患者，管腔CSA也会弥漫性减少30- 50%。尽管血管造影术已成为冠状动脉局灶性狭窄定义的“金标准”，但其诊断DCAD的可行性仍值得怀疑。因此，有一个显着的临床需要新的策略来诊断DCAD。该提案的总体目标是开发新的指数，用于诊断DCAD使用的冠状动脉的非侵入性成像，可转移到病人。将在DCAD动脉粥样硬化猪模型的研究中验证诊断矩阵。中心假设是人体冠状动脉树的设计遵循最小能量原则，这导致一组缩放定律;即，直径、长度、体积和流量之间的幂律关系。另一个假设是，标度律可以用作DCAD的敏感措施。标度定律提供了“正常”脉管系统的特征，并且与这些定律的偏差可用于量化DCAD的程度。我们独特的致动脉粥样硬化大型动物模型和正常和疾病患者的计算机断层扫描（CT）图像沿着我们的定量方法使我们能够进行拟议的研究。为了实现这一目标，我们设定了以下四个具体目标：1）开发一种有效的分割算法，用于形态测量数据的提取2）基于形态测量标度定律，使用从目标1中的CT图像获得的数据确定动脉粥样硬化DCAD猪模型中DCAD的诊断指数; 3）使用体内IVUS和死后心脏的组织病理学验证目标2中预测的DCAD指数;以及4）在医学上明确定义的正常和DCAD患者的回顾性队列中使用DCAD的验证指数。该提案的贡献将是提供常规成像中可见的心外膜冠状动脉树的综合分析，以诊断DCAD。公共卫生相关性：动脉粥样硬化仍然是美国发病率和死亡率的主要原因。弥漫性冠状动脉疾病（DCAD）是动脉粥样硬化的一种常见形式，尤其难以诊断，因为管腔横截面积沿沿着多条血管弥漫性地小于正常的管腔横截面积。该提案的贡献是提供常规成像中可见的心外膜冠状动脉树的综合分析，以诊断DCAD。